PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Transplantation. Author manuscript; available in PMC 2010 December 22.
Published in final edited form as:
Transplantation. 1991 October; 52(4): 749–751.
PMCID: PMC3007091
NIHMSID: NIHMS257358

EVIDENCE THAT CANINE PANCREATIC ISLETS PROMOTE THE SURVIVAL OF HUMAN HEPATOCYTES IN NUDE MICE1

In the last 15 years there have been numerous reports demonstrating that transplanted hepatocytes can retain hepatocellular functions (1), correct congenital enzyme deficiencies (24), and improve survival rates in animal models of acute hepatic failure (57). Recently, Moscioni et al. (8) showed that human liver cells attached to collagen-coated microcarriers (9, 10) were able to correct metabolic defects following transplantation into mutant rat recipients that were genetically deficient in either bilirubin-uridine diphosphate glucuronosyltransferase activity or albumin synthesis. Interestingly, the intraperitoneally injected hepatocyte-microcarriers that were well vascularized were almost exclusively found on the surface of the pancreas. This apparent cellular tropism raises questions about the presence and mechanism of action of pancreas-derived hepatotrophic factors and their role in the maintenance of hepatocyte integrity (1114).

The aim of this study was to determine the effect of pancreatic islets on the survival of human hepatocytes in an ectopic site in nude mice. Human hepatocytes were obtained from segments of preserved cadaver donor livers that had been discarded during size reduction procedures before transplantation of the residual fragments to pediatric recipients. A modification of the automated procedure for isolation of human pancreatic islets (15) was used for the isolation of hepatocyte aggregates. After cannulation of its portal branch, the liver segment was perfused with 200 ml of a solution of 1 mg/ml collagenase (Boehringer-Mannheim, type P) in Hanks solution (28°C) and placed into a digestion chamber. Separation of hepatocellular clusters was accomplished by the same separation procedure used previously for isolation of human pancreatic islets (15). Between 80% and 95% of the harvested hepatocytes were viable, as assessed by trypan blue exclusion. Collagen-coated microcarriers (Cytodex 3, Pharmacia Fine Chemicals, Upsala, Sweden) were prepared as described by Demetriou et al. (9). Pancreatic islets were obtained from the pancreata of mongrel dogs (18–25 kg) by a modification (16) of the automated method for human islet isolation (15).

Male BALB/c nude mice (20 g) were used as recipients in three groups (n=6 in each group). In group 1 (control) approximately 4000 hepatocyte clusters of an average diameter of 150 µ were placed beneath the left renal capsule as previously described (17). In group 2 (secondary control), hepatocyte clusters were transplanted in combination with 400 collagen-coated microcarriers. In group 3 the same number of hepatocyte clusters was transplanted without microcarriers but in combination with 400 pancreatic islets of 150 µm average diameter.

Thirty days after transplantation the nude mice were sacrificed and the morphologic integrity of the renal subcapsular grafts was determined histopathologically. Hematoxylin-eosin stain was used in all sections. In addition, immunostain for insulin (immunoperoxidase) was used in sections of combined islet-hepatocyte transplants to distinguish the islets from the hepatocellular implants.

The pathologist, who was blinded to the experimental groups from which the specimens came, correctly and without exception matched the tissues to the groups as follows. No hepatocytes were detectable in the renal subcapsular implants 1 month after transplantation of hepatocyte clusters alone (group 1). In group 2, the addition of collagen-coated microcarriers to the hepatocellular aggregates resulted in the survival of a thin rim of epithelioid cells attached to the microcarriers, while the remaining hepatocytes degenerated, leaving only fibrosis and a nonspecific mononuclear cell infiltrate around the microcarriers in the transplant site (Fig. 1). This suggested a minor augmentation of hepatocellular survival by the microcarrier. In contrast, when islets were included at the transplant site (group 3) multilayers of human hepatocytes were found. The surviving hepatocytes were healthy, in large clumps, and glycogen-containing, PAS-positive, and diastase-sensitive. These results are consistent with previous demonstrations that pancreatic-derived hepatotrophic factors are essential for maintenance of hepatocyte integrity (1114). Scattered pancreatic islets were detected (Fig. 2).

FIGURE 1
Photomicrograph of combined human hepatocytes and collagen-coated microcarriers 4 weeks after renal subcapsular transplantation. Degeneration of the hepatocytes occurred, leaving only a thin rim of epithelioid cells attached to the microcarriers (M) (H&E ...
FIGURE 2
Photomicrograph of combined human hepatocytes and dog pancreatic islets 4 weeks after renal subcapsular transplantation in nude mice. Insulin immunoperoxidase (dark) stain distinguished islets (I) from the human hepatocytes (H), which appeared well preserved ...

In past experience, when hepatocytes were transplanted by themselves in the presence of an intact host liver, no evidence of hepatocyte proliferation could be observed at any time after transplantation (18). Whenever cells without nuclei and multinucleated cells were found at the transplant site (19), hepatic degeneration had occurred. Similarly, it was not possible to detect the hepatocytes at either 2 or 4 days after intrasplenic transplantation (20), except when there was a proliferative stimulus provided by 70% recipient hepatectomy. Using the model of Demetriou et al. (9, 10), the collagen-coated hepatocyte microcarriers, the microcarriers may have promoted the survival of a small number of hepatocytes. In the earlier experiments of Moscioni et al. (8), the selective survival of the intraperitoneally injected hepatocyte-microcarrier aggregates on the surface of the pancreas was congruent with the possible role of factors produced from the pancreas in the maintenance of normal hepatocytes. Direct evidence supporting this concept (1114) has come from rodent experiments in which combined hepatocyte-islet clusters were placed in ectopic sites (21, 22).

The present study has established that human hepatocytes are subject to the hepatotrophic influence of islet cell factors, and because dog islets were used with human hepatocytes in the nude mouse recipient, it could be shown that the hepatotrophic effect was not species-specific. These findings will be important in defining effective procedures for the maintenance of human hepatocytes both in vitro and in vivo, and for their use in hepatocellular transplantation, artificial liver, and gene therapy applications.

Footnotes

1This work was supported by research grants from the Veterans Administration and by project grant DK 29961 from the National Institutes of Health, Bethesda, Maryland.

REFERENCES

1. Mito E, Ebata H, Kusano M, Onishi T. Morphology and function of isolated hepatocytes transplanted into rat spleen. Transplantation. 1979;28:499. [PubMed]
2. Matas AJ, Sutherland DE, Staffes MW, et al. Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science. 1976;192:892. [PubMed]
3. Groth CG, Arborgh B, Bjorken C, Lundren G. Correction of hyperbilirubinemia in the glucuronosyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc. 1977;19:313. [PubMed]
4. Vroemer JPAM, Buurman WA, Heirweg KPM, et al. Hepatocyte transplantation for enzyme deficiency disease in congeneic rats. Transplantation. 1986;42:130. [PubMed]
5. Sutherland DER, Numata M, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation in acute liver failure. Surgery. 1977;82:124. [PubMed]
6. Cuervas-Mons V, Cien Fuegos JA, Maganto P, et al. Time-related efficacy of liver cell isografts in fulminant hepatic failure. Transplantation. 1984;38:23. [PubMed]
7. Kwai Y, Price JB, Hardy MA. Reversal of liver failure in rats by ultraviolet-irradiated hepatocyte transplantation. Transplant Proc. 1987;19:989. [PubMed]
8. Moscioni AD, Chowdhury JR, Barbour R, et al. Human liver cell transplantation. Gastroenterology. 1989;96:1546. [PubMed]
9. Demetriou AA, Whiting JF, Feldman D, et al. Replacement of liver function in rate by transplantation of microcarrier-attached hepatocytes. Science. 1986;233:1190. [PubMed]
10. Demetriou AA, Levenson SM, Novikoff PM, et al. Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats. Proc Natl Acad Sci USA. 1986;83:7475. [PubMed]
11. Statzl TE, Lee IY, Porter KA, Putnam CW. The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet. 1975;140:381. [PMC free article] [PubMed]
12. Starzl TE, Putnam CW. The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet. 1975;140:549. [PMC free article] [PubMed]
13. Starzl TE, Porter KA, Watanabe K, et al. Effects of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet. 1976;1:821. [PubMed]
14. Starzl TE, Porter KA, Francavilla A. The Eck fistula in animals and humans. Curr Probl Surg. 1983;20:687. [PMC free article] [PubMed]
15. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes. 1988;37:413. [PubMed]
16. Tzakis A, Ricordi C, Alejandro R, et al. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet. 1990;336:402. [PMC free article] [PubMed]
17. Ricordi C, Lacy PE, Sterbenz K, Davie JM. Low temperature culture of human islets or in-vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc Natl Acad Sci USA. 1987;84:8080. [PubMed]
18. Cuervas-Mons V, Cienfuegos JA, Maganto P, et al. Long-term evaluation of isolated syngeneic hepatocytes transplanted into the normal rat spleen by TC-99M-HIDA scintigraphy. Transplantation. 1985;39:87. [PubMed]
19. Cuervas-Mons V, Canton T, Escandon J, et al. Monitoring the rejection of intrasplenic hepatocyte allografts and xenografts in the rat using technetium 99m-imidoacetic acid scanning. Transplant Proc. 1987;19:3850. [PubMed]
20. Makowa L, Lee G, Cobourn CS, et al. Allogeneic hepatocyte transplantation in the rat spleen under cyclosporine immunosuppression. Transplantation. 1986;424:537. [PubMed]
21. Ricordi C, Flye MW, Lacy PE. Renal subcapsular transplantation of clusters of hepatocyte in conjunction with pancreatic islets. Transplantation. 1988;45:1148. [PubMed]
22. Ricordi C, Lacy PE, Callery MP, Park PW, Flye MW. Trophic factors from pancreatic islets in combined hepatocyte-islet allografts enhance hepatocellular survival. Surgery. 1989;106:218. [PubMed]